These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14623733)

  • 1. A phase 1 trial of riluzole in spinal muscular atrophy.
    Russman BS; Iannaccone ST; Samaha FJ
    Arch Neurol; 2003 Nov; 60(11):1601-3. PubMed ID: 14623733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neonatal muscular spinal atrophy: a case report].
    Pavone P; Velardita M; Trigilia T; Luca G; Lucenti C; Romeo G; Falsaperla R
    Pediatr Med Chir; 2004; 26(2):139-41. PubMed ID: 15700740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of hydroxyurea in spinal muscular atrophy cells and patients.
    Liang WC; Yuo CY; Chang JG; Chen YC; Chang YF; Wang HY; Ju YH; Chiou SS; Jong YJ
    J Neurol Sci; 2008 May; 268(1-2):87-94. PubMed ID: 18166199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment for spinal muscular atrophy type I.
    Wadman RI; Bosboom WM; van den Berg LH; Wokke JH; Iannaccone ST; Vrancken AF
    Cochrane Database Syst Rev; 2011 Dec; (12):CD006281. PubMed ID: 22161399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal muscular atrophy.
    Iannaccone ST
    Semin Neurol; 1998; 18(1):19-26. PubMed ID: 9562664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Moore DH
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD001447. PubMed ID: 22419278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment for spinal muscular atrophy type I.
    Wadman RI; Bosboom WM; van der Pol WL; van den Berg LH; Wokke JH; Iannaccone ST; Vrancken AF
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006281. PubMed ID: 22513939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole.
    Sívori M; Rodríguez GE; Pascansky D; Sáenz C; Sica RE
    Medicina (B Aires); 2007; 67(4):326-30. PubMed ID: 17891927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riluzole and ALS therapy.
    Hugon J
    Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug treatment for spinal muscular atrophy type I.
    Bosboom W; Vrancken AF; van den Berg LH; Wokke J; Iannaccone ST
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006281. PubMed ID: 19160274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).
    Zoing MC; Burke D; Pamphlett R; Kiernan MC
    J Clin Neurosci; 2006 Jan; 13(1):78-83. PubMed ID: 16410201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor neuron disease: systematic reviews of treatment for ALS and SMA.
    Orrell RW
    Br Med Bull; 2010; 93():145-59. PubMed ID: 20015852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal recessive proximal spinal muscular atrophy in 101 sibs out of 48 families: clinical picture, influence of gender, and genetic implications.
    Rudnik-Schöneborn S; Röhrig D; Morgan G; Wirth B; Zerres K
    Am J Med Genet; 1994 May; 51(1):70-6. PubMed ID: 8030672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot trial of memantine and riluzole in ALS: correlation to CSF biomarkers.
    Levine TD; Bowser R; Hank N; Saperstein D
    Amyotroph Lateral Scler; 2010 Dec; 11(6):514-9. PubMed ID: 20839903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riluzole in Huntington's disease: a 3-year, randomized controlled study.
    Landwehrmeyer GB; Dubois B; de Yébenes JG; Kremer B; Gaus W; Kraus PH; Przuntek H; Dib M; Doble A; Fischer W; Ludolph AC;
    Ann Neurol; 2007 Sep; 62(3):262-72. PubMed ID: 17702031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: implications for clinical trials and genetic counselling.
    Rudnik-Schöneborn S; Berg C; Zerres K; Betzler C; Grimm T; Eggermann T; Eggermann K; Wirth R; Wirth B; Heller R
    Clin Genet; 2009 Aug; 76(2):168-78. PubMed ID: 19780763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.